ARM-201

Asset

Vectorized engineered microRNA regulates gene expression through RNA interference.

Stage
Preclinical
Modality
Gene therapy
Target
Not known
1
Indication
0
Trials
1
Developer

Indications

1
  • Facioscapulohumeral muscular dystrophy

    Preclinical, armatusbio.com, 10 Oct 2026

In the full profile

  • Owner and partners1
  • Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets